Latest FDA Stories
Today's announcement showcases the company's commitment to the development of minimally invasive, high efficacy, and cost effective orthopedic spine solutions CHICAGO, Jan.
The lawsuit is just one of a number of power morcellator lawsuits filed in the U.S.
Rapid adoption of AcceleDent continues as company advances orthodontic innovation with two new issued patents HOUSTON, Jan.
Largest-capacity Insulin Pump Cleared for People with Greater Insulin Needs SAN DIEGO, Jan. 12, 2015 /PRNewswire/ -- Tandem Diabetes Care(®), Inc.
New FDA Clearance Allows for the Ability of the Intact® Technology to Preserve Breast Lesion Architecture; Making a Reduction in Open Surgical Procedures a Potential FRAMINGHAM, Mass.,
-- DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease NORTH CHICAGO, Ill., Jan.
HILDEN, Germany and GERMANTOWN, Maryland, January 8, 2015 /PRNewswire/ -- - Ongoing growth with 250 new QIAsymphony placements in 2014 - Five FDA
HAYWARD, Calif., Jan. 8, 2015 /PRNewswire/ -- Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), today announced that the U.S.
Today, NCPDP addressed the FDA, CDER and ODAC meeting that met to review and make a recommendation on what may be the first biosimilar to receive FDA approval in the U.S., and potentially develop
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.